Your search returned 6 results.

Results
	1.	GSK2374697, a long duration glucagon-like peptide-1 (GLP-1) receptor agonist, reduces postprandial circulating endogenous total GLP-1 and peptide YY in healthy subjects. [electronic resource] by Lin, J Hodge, R J O'Connor-Semmes, R L Nunez, D J Producer: 20160630 In: Diabetes, obesity & metabolism vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary Cirrhosis. [electronic resource] by Zuo, P Dobbins, R L O'Connor-Semmes, R L Young, M A Producer: 20171013 In: CPT: pharmacometrics & systems pharmacology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Stereoselective pharmacokinetics of chlorpheniramine and the effect of ranitidine. [electronic resource] by Koch, K M O'Connor-Semmes, R L Davis, I M Yin, Y Producer: 19981007 In: Journal of pharmaceutical sciences vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Effect of ranitidine on the pharmacokinetics of triazolam and alpha-hydroxytriazolam in both young (19-60 years) and older (61-78 years) people. [electronic resource] by O'Connor-Semmes, R L Kersey, K Williams, D H Lam, R Koch, K M Producer: 20010920 In: Clinical pharmacology and therapeutics vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Use of the InteliSite capsule to study ranitidine absorption from various sites within the human intestinal tract. [electronic resource] by Pithavala, Y K Heizer, W D Parr, A F O'Connor-Semmes, R L Brouwer, K L Producer: 19990401 In: Pharmaceutical research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	GSK2374697, a novel albumin-binding domain antibody (AlbudAb), extends systemic exposure of exendin-4: first study in humans--PK/PD and safety. [electronic resource] by O'Connor-Semmes, R L Lin, J Hodge, R J Andrews, S Chism, J Choudhury, A Nunez, D J Producer: 20150130 In: Clinical pharmacology and therapeutics vol. 96 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)